Healthcare Professionals

Reveal LINQ

Insertable Cardiac Monitoring System

  • Reveal LINQ ICM Device

  

OVERVIEW

The World's Smallest, Most Accurate Insertable Cardiac Monitor1

The Reveal LINQ™ Insertable Cardiac Monitor is a wireless and powerfully small insertable cardiac monitor ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.

small - simple - 3 years

An Advanced Monitoring Solution

Image showing the elements of the advanced monitoring solutions and their modes of transmission

DEVICE LONGEVITY THAT OPTIMIZES DIAGNOSTIC YIELD

Image showing text: 30% Cryptogenic stroke AF diagnoses occur after 2 years – 20% Syncope diagnoses occur after 2 years - Long-term continuous data for ongoing AF management

INDICATIONS

The Reveal LINQ Insertable Cardiac Monitor is an implantable patient-activated and automatically-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:

  • patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
  • patients who experience transient symptoms such as dizziness, palpitation, syncope and chest pain, that may suggest a cardiac arrhythmia.

This device has not been specifically tested for pediatric use.

PRODUCT DETAILS

THE REVEAL LINQ SYSTEM ADVANTAGE

Actionable data to diagnose and treat even the most difficult-to-detect arrhythmias

Unmatched Accuracy Icon

UNMATCHED ACCURACY

Device innovations that provide leading detection accuracy

Superior Evidence Icon

SUPERIOR EVIDENCE

Clinical rigor that guides decisions across multiple conditions

Simplified Monitoring Icon

SIMPLIFIED MONITORING

Exclusive solutions that offer new freedom to focus on patients

UNMATCHED ACCURACY

Device innovations that provide leading detection accuracy

DRIVING ACCURACY EVOLUTION

Dedicated to advancing accuracy with every device generation

Timeline of the development progression of the Reveal device from 2009 to 2017
Industry-Leading TruRhythm Algorithms

Our newest detection algorithms streamline episodes without sacrificing sensitivity

Brady Pause Icon
Smart Filtering

Second sensing filter analyzes rhythms for possible undersensing in Brady and Pause

AF icon
Self-learning

AF algorithm learns and adapts to patients with sinus arrhythmia

 

SUPERIOR ACCURACY IN AF DETECTION

Demonstrating superior atrial fibrillation detection accuracy through our performance results*

Advanced AF Detection

Reveal LINQ Advanced AF Detection table comparing AF Burden and AF Episode details using Reveal LINQ and Confirm ACM

Streamlined Episode Review

Reveal LINQ Streamlined Episode Review chart comparing AF False Positives between Reveal LINQ and competitors

*Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.

SUPERIOR EVIDENCE

Clinical rigor that guides decisions across multiple conditions

HCPs Talking

MOST STUDIED

Evidence portfolio that includes 500+ published clinical articles and abstracts9

MOST VALIDATED

Clinical validation across cryptogenic stroke, syncope, and atrial fibrillation3,8,10

MOST UTILIZED

Data leveraged by clinical societies to develop treatment guidelines across indications11,12

CRYPTOGENIC STROKE

2016 ESC Guidelines for the Management of AF11

Long-term insertable cardiac monitoring recommended for cryptogenic stroke patients to document silent AF.

CRYSTAL AF Study3

Short- and intermediate-term cardiac monitoring may miss many patients with paroxysmal AF.

84 Days Icon

is the median time to AF detection in Cryptogenic Stroke patients

88 Percent Icon

of patients who had AF would have been missed if only monitored for 30 days

SYNCOPE

38 Percent Icon

more likely to reach a diagnosis with ICM than standard of care13

78 Percent Icon

of Reveal ICM patients with syncope recurrence received a differential diagnosis10

SYNCOPE

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope12

Insertable cardiac monitoring recommended for syncope patients with
infrequent symptoms > 30 days apart.

2018 ESC Guidelines for the Diagnosis and Management of Syncope13

Insertable cardiac monitoring recommended for early monitoring in low-risk syncope patients and after workup of high-risk patients.

ATRIAL FIBRILLATION

Reveal AF Study14

AF detection increases over time for patients at high risk for AF and stroke.

40 Percent Icon

AF detection rate at 30 months

84.5 Percent Icon

of patients with AF would have been missed if only monitored for 30 days

SIMPLIFIED MONITORING

FREEDOM TO FOCUS ON BETTER PATIENT CARE

Exclusive solutions keep you connected to your patients, while turning device data into actionable insights

Reveal LINQ Mobile Manager
APP-BASED INSERTION WORK FLOW

Reveal LINQ Mobile Manager

Manage device registration, activation, CareLink™ pre-enrollment and patient education — right from your tablet.

Reveal LINQ Mobile Manager Info >

CareLink Network Image
MORE EFFICIENT DATA MANAGEMENT

Enhanced CareLink™ Network

Move critical transmissions to the forefront and assess/adjudicate episodes right from the improved Quick Look™ page.

CareLink Network Info >

Reveal LINQ Monitoring Service Technician
A VIRTUAL EXTENSION OF YOUR CLINICAL TEAM

Reveal LINQSM Monitoring Service

Streamline patient management with support from certified technicians who ensure ongoing data transmission, review cardiac data, and provide clinically actionable reports.

Reveal LINQ Monitoring Service Info >

MANUALS AND TECHNICAL GUIDES

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Reveal LINQ) or model number (LNQ11). You may also call 800-961-9055 for a copy of a manual.

MODEL SPECS

Reveal LINQ LNQ11 Specifications

DESCRIPTION SPECS

Volume

1.2 cc

Dimensions

44.8 mm x 7.2 mm x 4.0 mm

Mass

2.5 g ± 0.5

Distance between electrodes

37.7 mm

MRI Compatibility

3.0 and 1.5 Tesla with no post-insertion waiting period required*

Battery Longevity

Projected 3 Years2
pdf Reveal LINQ ICM Specifications (.pdf)

2.1MB

Image of the Reveal LINQ product specifications sheet
1

ICM Competitive Comparison Guide. Medtronic data on file. 2017.

2

Reference the Reveal LINQ ICM Clinician Manual for usage parameters.

3

Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. June 26, 2014;370(26):2478-2486.

4

Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol. January 2012;23(1):67-71.

5

TruRhythm Detection Algorithms. Medtronic data on file. 2017.

6

Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.

7

Biotronik BioMonitor 2 Clinical Manual. 2016.

8

Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized ICM: Results from the Reveal LINQ Usability Study. Heart Rhythm. July 2016;13(7):1425-1430.

9

Medtronic Reveal Publications. Medtronic data on file. 2016.

10

Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. February 2011;13(2):262-269.

11

Kirchhof P, Benussi, S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. October 7, 2016;37(38):2893-2962.

12

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

13

Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. June 1, 2018;39(21):1883-1948.

14

Reiffel JA, Verma A, Kowey PR, et al. High Incidence of Previously Unknown (“Silent”) Atrial Fibrillation in Patients at High Risk for Atrial Fibrillation and Stroke: Primary Results from the REVEAL AF Study. Abstract presented at Heart Rhythm Society Annual Scientific Sessions. 2017.